Compare Anti-VEGF

4 products »

close Created with Sketch.

Macugen

Bausch + Lomb Inc.

Macugen (pegaptanib sodium injection) is indicated for the treatment of neovascular (wet) age-related macular degeneration.

At-a-Glance
  • Mechanism of Action: Pegaptanib is a selective vascular endothelial growth factor (VEGF) antagonist. It is an aptamer, a pegylated modified oligonucleotide, which adopts a three-dimensional conformation that enables it to bind to extracellular VEGF.
  • Dosage

Details

FDA

Yes

CE Mark

Yes

Active Ingredients

Pegaptanib sodium

Application

Intravitreal

Status

Prescription

Strength

EQ 0.3MG ACID/0.09ML

Company Information

Contact the company for additional information, availability, or pricing:

Bausch + Lomb Inc.

bausch.com

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807